CryoLife, Inc. (NYSE:CRY)

CAPS Rating: 5 out of 5

The Company develops and commercializes biomaterials, implantable medical devices, and preserves and distributes human tissues for cardiovascular and vascular transplant applications.

Recs

0
Player Avatar ztur2218 (< 20) Submitted: 5/24/2009 4:03:16 AM : Outperform Start Price: $4.72 CRY Score: -53.39

big discounted stock

Featured Broker Partners


Advertisement